Is cagrilintide approved by the FDA?

No, it remains investigational in the US, UK, Australia, and Canada. It has been studied on its own and, more prominently, combined with semaglutide as CagriSema, aiming for weight loss beyond what either drug achieves alone. Until it clears FDA review, cagrilintide sold to individuals is an unapproved research chemical, not a prescription medicine.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.